dapi has been researched along with lovastatin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amara, F; Arthur, G; Dibrov, A; He, Y; Kashour, T; Salins, P; Shawesh, S | 1 |
1 other study(ies) available for dapi and lovastatin
Article | Year |
---|---|
Lovastatin protects human neurons against Abeta-induced toxicity and causes activation of beta-catenin-TCF/LEF signaling.
Topics: Amyloid beta-Peptides; Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Cell Differentiation; Cell Line, Tumor; Enzyme Activation; Humans; In Situ Nick-End Labeling; Indoles; Lovastatin; Lymphoid Enhancer-Binding Factor 1; Neuroblastoma; Neurons; Neuroprotective Agents; Peptide Fragments; Signal Transduction; Time Factors | 2007 |